Managing infection in cancer patients and other immunocompromised children

Area of Science:

• Pediatric Immunology
• Infectious Diseases
• Oncology

Background:

• Children undergoing immunosuppressive therapy (e.g., for cancer, organ transplant) and those with primary immunodeficiency share high susceptibility to diverse pathogens.
• These patients are at increased risk for microbial reactivation, especially viral infections, during immunosuppression.

Purpose of the Study:

• To review the management strategies for infections in children with primary or acquired immunodeficiency.
• To highlight the critical need for early recognition and treatment of infections in immunosuppressed pediatric populations.

Main Methods:

• Review of clinical approaches to prophylactic and definitive antimicrobial therapy.
• Examination of management experiences from primary immunodeficiency cases applied to acquired immunodeficiency.

Main Results:

• Consistent infections include bacteremia (especially with central venous lines), Pneumocystis jirovecii pneumonia, herpes virus infections, and opportunistic fungal infections.
• Prophylactic therapy is warranted for frequent infections in defined groups, with careful attention to duration to prevent resistance.
• Higher safe dosages and longer durations of antimicrobial therapy are recommended for established infections.

Conclusions:

• Effective management of infections in immunosuppressed children requires a thorough understanding of pathogen types and host immune status.
• Tailoring empiric therapy based on immune suppression type (e.g., neutropenia, cellular immunity) and risk factors (e.g., central venous lines) is crucial.
• Optimizing antimicrobial therapy, including appropriate prophylaxis and treatment durations, is essential for improving outcomes in pediatric patients with immunodeficiency.